XT
PRAX icon

XTX Topco’s Praxis Precision Medicines PRAX Stock Holding History

XTX Topco’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Sell
1,175
-169
-13% -$53.5K 0.01% 2673
2026
Q1 		$433K Buy
+1,344
New +$416K 0.01% 2172
2025
Q2 		– Sell
-10,043
Closed -$380K – 2993
2025
Q1 		$380K Buy
+10,043
New +$627K 0.02% 1226
2023
Q3 		– Sell
-1,209
Closed -$20.9K – 1920
2023
Q2 		$20.9K Buy
+1,209
New +$18.5K ﹤0.01% 1317
2023
Q1 		– Sell
-9,867
Closed -$352K – 1582
2022
Q4 		$352K Buy
9,867
+941
+11% +$29.3K 0.07% 486
2022
Q3 		$304K Buy
8,926
+4,180
+88% +$208K 0.08% 492
2022
Q2 		$174K Buy
+4,746
New +$507K 0.07% 499

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

XTX Topco's PRAX Position: Q2 2026 in Review

XTX Topco reduced its Praxis Precision Medicines (PRAX) stake by 13% in Q2 2026, selling an estimated $53.5K and leaving 1,175 shares worth $393K. The position accounts for 0.01% of the portfolio, ranked #2673.

XTX Topco first reported a position in PRAX in Q2 2022 and has held it in 7 quarters since. The position peaked at $433K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • XTX Topco held 1,175 shares of Praxis Precision Medicines worth $393K as of Q2 2026.
  • XTX Topco sold 169 Praxis Precision Medicines shares in Q2 2026, an estimated $53.5K.
  • Praxis Precision Medicines made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2673 holding.
  • XTX Topco first reported a position in Praxis Precision Medicines in Q2 2022 and has held it in 7 quarters since.
  • XTX Topco's Praxis Precision Medicines position peaked at $433K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.